Skip to main content

Advertisement

SpringerLink
Log in

High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer

  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Background

The expression of Heat Shock Proteins (HSPs) is increased in various cancers and has been shown to correlate with biological tumor behaviour. This study aimed to investigate the impact of HSP70, HSP60 and HSP27 expression in colon cancer.

Material and methods

HSP expression was determined by immunohistochemistry on a tissue microarray with 355 primary resected colon carcinomas of all stages. Expression patterns were correlated with pathologic features (UICC pTNM category, tumor grading) and survival.

Results

Expression of HSP27, HSP60 and HSP70 ranged from negative to high. There was no correlation between HSP27, HSP60 and HSP70 expression among each other and with UICC pT category, presence of lymph node or distant metastases or tumor grading. High HSP70 expression was associated with worse overall survival (p < 0.001) and was an independent prognostic factor (p = 0.004) in multivariate analysis including the pathological parameters mentioned above. For patients without lymph node or distant metastases (UICC stages I/II) and with complete tumor excision, HSP70 expression was the only independent prognostic factor for survival (p = 0.001) and superior to UICC pT category. In left sided UICC stage I/II carcinomas, high HSP27 expression also had adverse prognostic impact and was an independent prognostic factor (p = 0.016) besides HSP70 (p = 0.002).

Conclusion

High HSP70 and HSP27 expression is associated with worse clinical outcome in colon cancer. Determination of tumoral HSP70 and HSP27 may be used as additional biomarker for risk stratification especially for UICC stage I/II patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. J. Ferlay, H.-R. Shin, F. Bray et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893–2917 (2010)

    Article  PubMed  CAS  Google Scholar 

  2. A. Jemal, R. Siegel, E. Ward et al., Cancer statistics, 2009. CA Cancer J. Clin. 59, 225–249 (2009)

    Article  PubMed  Google Scholar 

  3. D.V.T. Catenacci, M. Kozloff, H.L. Kindler, B. Polite, Personalized Colon Cancer Care in 2010. Semin. Oncol. 38, 284–308 (2011)

    Article  PubMed  CAS  Google Scholar 

  4. L. Sobin, M.L. Gospodarowicz, Ch Wittekind, TNM classification of malignant tumors (John Wiley & Sons, New York, 2010)

    Google Scholar 

  5. M.G. Mutch, Molecular profiling and risk stratification of adenocarcinoma of the colon. J. Surg. Oncol. 96, 693–703 (2007)

    Article  PubMed  Google Scholar 

  6. S. Tejpar, M. Bertagnolli, F. Bosman et al., Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist 15, 390–404 (2010)

    Article  PubMed  CAS  Google Scholar 

  7. S. Lindquist, E.A. Craig, The heat-shock proteins. Annu. Rev. Genet. 22, 631–677 (1988)

    Article  PubMed  CAS  Google Scholar 

  8. S.K. Calderwood, M.A. Khaleque, D.B. Sawyer, D.R. Ciocca, Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31, 164–172 (2006)

    Article  PubMed  CAS  Google Scholar 

  9. D.R. Ciocca, S.K. Calderwood, Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10, 86–103 (2005)

    Article  PubMed  CAS  Google Scholar 

  10. A.A. Khalil, N.F. Kabapy, S.F. Deraz, C. Smith, Heat shock proteins in oncology: Diagnostic biomarkers or therapeutic targets? Biochim. Biophys. Acta 1816, 89–104 (2011)

    PubMed  CAS  Google Scholar 

  11. M. Sherman, G. Multhoff, Heat shock proteins in cancer. Ann. N. Y. Acad. Sci. 1113, 192–201 (2007)

    Article  PubMed  CAS  Google Scholar 

  12. F. Cappello, S. David, F. Rappa et al., The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer 5, 139 (2005)

    Article  PubMed  Google Scholar 

  13. T.S. Hwang, H.S. Han, H.K. Choi et al., Differential, stage-dependent expression of Hsp70, Hsp110 and Bcl-2 in colorectal cancer. J. Gastroenterol. Hepatol. 18, 690–700 (2003)

    Article  PubMed  Google Scholar 

  14. Y. Kanazawa, H. Isomoto, M. Oka et al., Expression of heat shock protein (Hsp) 70 and Hsp 40 in colorectal cancer. Med Oncol 20, 157–164 (2003)

    Article  PubMed  CAS  Google Scholar 

  15. X.P. Wang, G.Z. Liu, A.L. Song et al., Expression and significance of heat shock protein 70 and glucose-regulated protein 94 in human esophageal carcinoma. World J. Gastroenterol. 11, 429–432 (2005)

    PubMed  Google Scholar 

  16. K. Pfister, J. Radons, R. Busch et al., Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis. Cancer 110, 926–935 (2007)

    Article  PubMed  Google Scholar 

  17. J. Kocsis, T. Meszaros, B. Madaras et al., High levels of acute phase proteins and soluble 70 kDa heat shock proteins are independent and additive risk factors for mortality in colorectal cancer. Cell Stress Chaperones 16, 49–55 (2011)

    Article  PubMed  CAS  Google Scholar 

  18. A.B. Benson, D. Schrag, M.R. Somerfield et al., American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer. J. Clin. Oncol. 22, 3408–3419 (2004)

    Article  PubMed  Google Scholar 

  19. J.L. Marshall, D.G. Haller, A. de Gramont et al., Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal Oncology. Gastrointest Cancer Res 1, 146–154 (2007)

    PubMed  Google Scholar 

  20. T. Andre, A. de Gramont, An overview of adjuvant systemic chemotherapy for colon cancer. Clin. Colorectal Cancer 4(Suppl 1), S22–S28 (2004)

    Article  PubMed  CAS  Google Scholar 

  21. E.M. Tweedle, I. Khattak, C.W. Ang et al., Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer. Gut 59, 1501–1510 (2010)

    Article  PubMed  CAS  Google Scholar 

  22. A. Marx, P. Simon, R. Simon et al., AMACR expression in colorectal cancer is associated with left-sided tumor localization. Virchows Archiv 453, 243–248 (2008)

    Article  PubMed  CAS  Google Scholar 

  23. B. Iacopetta, Are there two sides to colorectal cancer? Int. J. Cancer 101, 403–408 (2002)

    Article  PubMed  CAS  Google Scholar 

  24. R. Langer, K. Ott, K. Specht et al., Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy response. Clin. Cancer Res. 14, 8279–8287 (2008)

    Article  PubMed  CAS  Google Scholar 

  25. C.S. Wong, V.W. Wong, C.M. Chan et al., Identification of 5-fluorouracil response proteins in colorectal carcinoma cell line SW480 by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. Oncol Rep 20, 89–98 (2008)

    PubMed  CAS  Google Scholar 

  26. M. Tsuruta, H. Nishibori, H. Hasegawa et al., Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Oncol Rep 20, 1165–1172 (2008)

    PubMed  CAS  Google Scholar 

  27. D.H. Choi, J.S. Ha, W.H. Lee et al., Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells. FEBS Lett. 581, 1649–1656 (2007)

    Article  PubMed  CAS  Google Scholar 

  28. V. Dudeja, S.M. Vickers, A.K. Saluja, The role of heat shock proteins in gastrointestinal diseases. Gut 58, 1000–1009 (2009)

    Article  PubMed  CAS  Google Scholar 

  29. G. Jego, A. Hazoume, R. Seigneuric, C. Garrido, Targeting heat shock proteins in cancer. Cancer Lett (2010)

  30. Y. Fukuyo, C.R. Hunt, N. Horikoshi, Geldanamycin and its anti-cancer activities. Cancer Lett. 290, 24–35 (2010)

    Article  PubMed  CAS  Google Scholar 

  31. U. Banerji, Heat Shock Protein 90 as a Drug Target: Some Like It Hot. Clin. Cancer Res. 15, 9–14 (2009)

    Article  PubMed  CAS  Google Scholar 

  32. A. Aghdassi, P. Phillips, V. Dudeja et al., Heat shock protein 70 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 67, 616–625 (2007)

    Article  PubMed  CAS  Google Scholar 

  33. P.A. Phillips, V. Dudeja, J.A. McCarroll et al., Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res. 67, 9407–9416 (2007)

    Article  PubMed  CAS  Google Scholar 

  34. Z.P. Yuan, L.J. Chen, L.Y. Fan et al., Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res. 12, 3193–3199 (2006)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Mrs Melitta Winkler for expert technical assistance. This study was supported by the Deutsche Forschungsgemeinschaft (DFG), grant number LA2706/1-1.

Conflict of Interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Institute of Pathology, Technische Universität München, Trogerstr. 18, 81675, Munich, Germany

    Karina Bauer, Julia Slotta-Huspenina, Enken Drecoll, Claus Hann von Weyhern, Heinz Höfler & Rupert Langer

  2. Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, Munich, Germany

    Ulrich Nitsche & Robert Rosenberg

  3. Institute of Pathology, Städtisches Klinikum München, Klinikum Harlaching, Sanatoriumsplatz 2, 81545, Munich, Germany

    Claus Hann von Weyhern

  4. Department of Surgery, Kantonsspital Baden, 5404, Baden, Switzerland

    Robert Rosenberg

  5. Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstr. 1, 85764, Neuherberg, Germany

    Heinz Höfler

  6. Institute of Pathology, University of Bern, Murtenstr. 31, 3010, Bern, Switzerland

    Rupert Langer

Authors
  1. Karina Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrich Nitsche
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Julia Slotta-Huspenina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Enken Drecoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claus Hann von Weyhern
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert Rosenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heinz Höfler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rupert Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rupert Langer.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 81 kb)

ESM 2

(PDF 114 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauer, K., Nitsche, U., Slotta-Huspenina, J. et al. High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer. Cell Oncol. 35, 197–205 (2012). https://doi.org/10.1007/s13402-012-0079-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-012-0079-3

Keywords

Search

Navigation